News

Treatment will be carried out in CF patients aged six and older who have one of eight additional mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

The MHRA has agreed to act as the Reference Member State for this Decentralised Procedure, which will include the UK, Denmark and Sweden. Elvanse is the first long-acting

The CHMP’s recommendation is now referred to the European Commission (EC) and if approved, the company will receive marketing authorization for Vimizim in all EU Member States. The

CVac is a personalized immunocellular therapeutic product and is currently under investigation for the treatment of epithelial ovarian cancer. The drug is intended to stimulate the immune system

The main aim of the deal is to increase the volume of clinical trials carried out in Germany, improve access to commercial clinical research for patients, accelerate the

Preeclampsia is one of the most common medical complications of pregnancy, and if left untreated it can progress to eclampsia, the life-threatening occurrence of seizures during pregnancy. It

This phase of the COMPACT program will assess the efficacy and safety of a new formulation of the CSL Behring C1-INH concentrate in preventing hereditary angioedema attacks when

The goal of this grant is to provide scientific leadership and infrastructure for laboratory testing as part of the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network.

Designed by Zimmer Gunsul Frasca Architects (ZGF), the three-story, 45,000-square-foot building is an apt tribute to its prominent, coastal location, with its long, slender shape. Exposed architectural concrete